28 April 2026 Stratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeutics Stratosvir has received support from Cell and Gene Therapy Catapult (CGT Catapult), including investment from the Cross Catapult Investment Pilot. Member news
27 April 2026 BIA update – 27 April 2026 It has been an extremely challenging time for biotech post COVID-19 boom, but our Q1 financing report offers hope with continued positive momentum. Blog
15 April 2026 PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in 2026 PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in 2026. Member news
15 April 2026 MHRA grants clinical trial authorisation for the POLB 001 TOPICAL trial The UK Medicines and Healthcare products Regulatory Agency has granted Clinical Trial Authorisation for the POLB 001 TOPICAL trial. Member news
31 March 2026 Semarion secures $3.8 million to scale next-generation cell assay technology and accelerate pharma adoption Semarion has raised $3.8 million USD (£2.9 million GBP) Member news
31 March 2026 Milner Institute to showcase collaboration and innovation at BioTrinity 2026 We’re delighted to announce that the Milner Therapeutics Institute will play an active role at BioTrinity 2026! Member news